The legacy of Viagra and its impact on the pharmaceutical landscape presents a complex question for investors . Initially a blockbuster drug, copycat medications have significantly eroded its market dominance, creating challenges for companies involved to the original patent holder and related advancements . While some firms might benefit from focu